UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014402
Receipt number R000016717
Scientific Title Effects of cilostazol on cerebarl vasospasm after subarachnoid hemorrhage
Date of disclosure of the study information 2014/06/27
Last modified on 2016/09/11 08:10:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of cilostazol on cerebarl vasospasm after subarachnoid hemorrhage

Acronym

Effects of cilostazol on cerebral vasospasm

Scientific Title

Effects of cilostazol on cerebarl vasospasm after subarachnoid hemorrhage

Scientific Title:Acronym

Effects of cilostazol on cerebral vasospasm

Region

Japan


Condition

Condition

subarachnoid hemorrhage

Classification by specialty

Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Objective is to evaluate effect of cilostazol on cerebral vasospasm after subarachnoid hemorrhage, change of neurological symptom, side effect, and long-term prognosis by double-blind test.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

occurrence of symptomatic vasospasm

Key secondary outcomes

1) angiographic vasospasm on digital subtraction angiography
2) cerebral infarction due to cerebral vasospasm on CT scan
3) functional outcome (m-RS, GOS)
4) adverse event


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

cilostazol

Interventions/Control_2

placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Ruptured aneurysm was secured by clipping or coiling within 24 hours after the onset of SAH, and oral administration of placebo or cilostazol was started within 48 hours after the onset of SAH.
3. SAH should be diffuse or localized thick subarachnoid clot on CT scan performed within 24 hours of SAH.
2. clinical grade evaluated by a World Federation of Neurological Surgeons Grade or Hunt and Hess Grade was 1 to 4 before clipping or coiling.

Key exclusion criteria

1. Pre-existing major hepatic, renal, pulmonary or cardiac disease.
2. prior cerebral damage of past history of stroke or traumatic brain injury confirmed by CT scan.
3. focal neurological deficits on admission due to accompanying intracerebral clot.
4. current use of anti-platelet and/or anticoagulant agent.
5. operative neurological deficits arisen due to clipping or coiling procedure.
6.drug allergy
7. pregnancy.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroki Ohkuma

Organization

Hirosaki University Graduate School of Medicine

Division name

Department of Neurosurgery

Zip code


Address

5 Zaifu-cho Hirosaki, Aomori

TEL

0172-39-5115

Email

ohkuma@hirosaki-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masato Naraoka

Organization

Hirosaki University Graduate School of Medicine

Division name

Department of Neurosurgery

Zip code


Address

5 Zaifu-cho Hirosaki, Aomori

TEL

0172-39-5115

Homepage URL


Email

Nessun@hirosaki-u.ac.jp


Sponsor or person

Institute

Hirosaki University Graduate School of Medicine Department of Neurosurgery

Institute

Department

Personal name



Funding Source

Organization

Hirosaki University Graduate School of Medicine Department of Neurosurgery

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Kuroishi General Hospital
Aomori City Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

弘前大学大学院医学研究科(青森県)


Other administrative information

Date of disclosure of the study information

2014 Year 06 Month 27 Day


Related information

URL releasing protocol

http://www.med.hirosaki-u.ac.jp/web/index.html

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 07 Month 30 Day

Date of IRB


Anticipated trial start date

2010 Year 08 Month 30 Day

Last follow-up date

2013 Year 12 Month 31 Day

Date of closure to data entry

2014 Year 06 Month 27 Day

Date trial data considered complete

2014 Year 06 Month 27 Day

Date analysis concluded

2014 Year 07 Month 30 Day


Other

Other related information



Management information

Registered date

2014 Year 06 Month 27 Day

Last modified on

2016 Year 09 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016717


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name